Alpha Teknova (TKNO)

• Market cap: $242M
• 1 day: -0.22%
• 5 days: 6.35%
• 1 month: 2.49%
• 3 months: -17.52%
• 6 months: -20%
• Year to date: -45.67%
• 1 year: 2.73%
• 5 years: -81.92%
• 10 years: -81.92%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Employees: 173

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

286% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 7

20% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 20

19% more capital invested

Capital invested by funds: $31.7M [Q1] → $37.6M (+$5.88M) [Q2]

6% more funds holding

Funds holding: 64 [Q1] → 68 (+4) [Q2]

2.9% more ownership

Funds ownership: 11.45% [Q1] → 14.34% (+2.9%) [Q2]

100% less funds holding in top 10

Funds holding in top 10: 1 [Q1] → 0 (-1) [Q2]